chr17-42990322-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_173079.5(RUNDC1):c.862G>A(p.Val288Met) variant causes a missense change. The variant allele was found at a frequency of 0.000236 in 1,613,502 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00018 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00024 ( 0 hom. )
Consequence
RUNDC1
NM_173079.5 missense
NM_173079.5 missense
Scores
3
5
11
Clinical Significance
Conservation
PhyloP100: 6.24
Genes affected
RUNDC1 (HGNC:25418): (RUN domain containing 1) This gene encodes a protein that contains a RUN (RPIP8, UNC-14 and NESCA) domain and a coiled coil domain. The encoded protein may negatively regulate p53 transcriptional activity. This gene is a potential candidate gene for predisposition to glioma in humans. [provided by RefSeq, May 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23682845).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNDC1 | NM_173079.5 | c.862G>A | p.Val288Met | missense_variant | 4/5 | ENST00000361677.6 | NP_775102.3 | |
RUNDC1 | NM_001321381.3 | c.868G>A | p.Val290Met | missense_variant | 5/6 | NP_001308310.2 | ||
RUNDC1 | NM_001394222.1 | c.862G>A | p.Val288Met | missense_variant | 4/5 | NP_001381151.1 | ||
RUNDC1 | XM_005257078.5 | c.868G>A | p.Val290Met | missense_variant | 5/6 | XP_005257135.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNDC1 | ENST00000361677.6 | c.862G>A | p.Val288Met | missense_variant | 4/5 | 1 | NM_173079.5 | ENSP00000354622.1 | ||
RUNDC1 | ENST00000589705.1 | c.657G>A | p.Lys219Lys | synonymous_variant | 3/4 | 5 | ENSP00000467953.1 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152220Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
28
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000255 AC: 64AN: 250542Hom.: 0 AF XY: 0.000310 AC XY: 42AN XY: 135468
GnomAD3 exomes
AF:
AC:
64
AN:
250542
Hom.:
AF XY:
AC XY:
42
AN XY:
135468
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000242 AC: 353AN: 1461282Hom.: 0 Cov.: 31 AF XY: 0.000239 AC XY: 174AN XY: 726930
GnomAD4 exome
AF:
AC:
353
AN:
1461282
Hom.:
Cov.:
31
AF XY:
AC XY:
174
AN XY:
726930
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000184 AC: 28AN: 152220Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74360
GnomAD4 genome
AF:
AC:
28
AN:
152220
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
74360
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
8
ExAC
AF:
AC:
41
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 21, 2021 | The c.862G>A (p.V288M) alteration is located in exon 4 (coding exon 4) of the RUNDC1 gene. This alteration results from a G to A substitution at nucleotide position 862, causing the valine (V) at amino acid position 288 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Benign
T
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at